Combination Therapy in Hypertension with Diabetes: Preferential Consideration for CCB and ARBs Dr. Pramila Kalra4 Jan 2021 12:45 PM ISTThe last edition of the International Diabetes Federation (IDF) Atlas offered projections that continue to put India at the second slot in the...
PARALLAX meets one primary endpoint in heart failure with preserved ejection fraction Hina Zahid8 Sept 2020 11:20 AM ISTSophia Antipolis, France - Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does...
Amlodipine and Cardiovascular outcomes in Hypertensive patients: What Meta-analysis says Dr. Prem Aggarwal17 Aug 2020 12:30 PM ISTA major risk factor for cardiovascular disease is hypertension. A multitude of drugs, including calcium channel blockers (CCBs), β-blockers,...
High BP drugs safe for patients with COVID-19 disease, finds Study Hina Zahid3 May 2020 1:45 PM ISTIn a study of 12,594 patients it has been found that common high blood pressure drugs did not increase the risk of contracting COVID-19 - or of...
ACEIs and ARBs may improve prognosis of high BP patients with COVID-19, finds review Dr. Kamal Kant Kohli31 March 2020 8:24 AM ISTRochester, MN, - Researchers after reviewing studies have concluded that ACEIs and ARBs, may have a role to play in the treatment of COVID-19 and may...
